India got it earlier this year, and Canada approved it last month. But when is the United States going to get a generic version of Ozempic? Subscribe to read this story ad-free Get unlimited access to ...

Mortgage lenders are rushing to adopt AI, but many are repeating a familiar mistake: using new technology to accelerate old processes. Faster paper-pushing isn’t transformation. AI presents an ...

May 1 (Reuters) - We also report on a new use for artificial intelligence that could help eliminate some racial inequities in heart disease diagnoses. MODIFIED T-CELL THERAPY MAY AVOID NEED FOR ...

The era of cheap, officially approved semaglutide is finally here—in Canada, that is. The country has just become the first in North America and the first G7 nation to license a generic version of the ...

Business-to-business didn’t lose its voice to AI. It gave it away long before. Tara Allison, chief marketing officer of Advania UK, argues that today’s content crisis is rooted in safe, ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

Richard L. Jackson is the founder and CEO of Jackson Healthcare, the parent company of USAntibiotics. The United States leads the world in pharmaceutical innovation. But it is less successful in ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

WASHINGTON, Dec 3 (Reuters) - AT&T (T.N), opens new tab and its employee benefit trust have sued dozens of generic drug manufacturers in U.S. federal court, accusing them of orchestrating an ...